---
pmid: '20144646'
title: 'Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson
  disease.'
authors:
- Dachsel JC
- Nishioka K
- Vilariño-Güell C
- Lincoln SJ
- Soto-Ortolaza AI
- Kachergus J
- Hinkle KM
- Heckman MG
- Jasinska-Myga B
- Taylor JP
- Dickson DW
- Gibson RA
- Hentati F
- Ross OA
- Farrer MJ
journal: Mech Ageing Dev
year: '2010'
full_text_available: false
pmcid: PMC2847049
doi: 10.1016/j.mad.2010.01.009
---

# Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease.
**Authors:** Dachsel JC, Nishioka K, Vilariño-Güell C, Lincoln SJ, Soto-Ortolaza AI, Kachergus J, Hinkle KM, Heckman MG, Jasinska-Myga B, Taylor JP, Dickson DW, Gibson RA, Hentati F, Ross OA, Farrer MJ
**Journal:** Mech Ageing Dev (2010)
**DOI:** [10.1016/j.mad.2010.01.009](https://doi.org/10.1016/j.mad.2010.01.009)
**PMC:** [PMC2847049](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847049/)

## Abstract

1. Mech Ageing Dev. 2010 Mar;131(3):210-4. doi: 10.1016/j.mad.2010.01.009. Epub 
2010 Feb 6.

Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson 
disease.

Dachsel JC(1), Nishioka K, Vilariño-Güell C, Lincoln SJ, Soto-Ortolaza AI, 
Kachergus J, Hinkle KM, Heckman MG, Jasinska-Myga B, Taylor JP, Dickson DW, 
Gibson RA, Hentati F, Ross OA, Farrer MJ.

Author information:
(1)Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, 4500 San 
Pablo Road, Jacksonville, FL 32224, USA. daechsel.justus@mayo.edu

LRRK2 mutations are recognized as the most frequent genetic cause of both 
familial and sporadic parkinsonism identified to date. A remarkable feature of 
this form of parkinsonism is the variable penetrance of symptom manifestation 
resulting in a wide range of age-at-onset in patients. Herein we use a 
functional approach to identify the Lrrk1 protein as a potential disease 
modifier demonstrating an interaction and heterodimer formation with Lrrk2. In 
addition, evaluation of LRRK1 variants in our large Lrrk2 p.G2019S-parkinsonism 
series from a Tunisian (n=145) identified a missense mutation (p.L416M) 
resulting in an average 6.2 years younger age at disease onset. In conclusion we 
show that the interaction of Lrrk1-Lrrk2 can form protein dimers and this 
interaction may influence the age of symptomatic manifestation in 
Lrrk2-parkinsonism patients.

2010 Elsevier Ireland Ltd. All rights reserved.

DOI: 10.1016/j.mad.2010.01.009
PMCID: PMC2847049
PMID: 20144646 [Indexed for MEDLINE]
